GSK3358699
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK3358699, covering 2020-12-02 to 2020-12-02. Get the full timeline:
Most recent: Clinical Trial Update: First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699 [Phase 1]